Abera Bioscience

6,82 SEK

+3,02%

Mindre end 1K følgere

ABERA

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+3,02 %
+13,67 %
+17,59 %
+0,29 %
+8,25 %
-19,76 %
+33,73 %
-45,44 %
-38,28 %

Abera Bioscience is a Swedish biotechnology company that develops nasal vaccines based on a proprietary OMV-based platform technology. The company's focus is on nasal vaccines that provide immune responses in both mucosal and systemic areas. Abera develops vaccines against several respiratory infectious diseases, including pneumococci, influenza and pandemic preparedness, with projects in preclinical and planned clinical phases. The company was founded in 2012 and is headquartered in Uppsala.

Læs mere
Markedsværdi
139,8 mio. SEK
Aktieomsætning
82,86 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
12.5
2026

Delårsrapport Q1'26

10.6
2026

Generalforsamling '26

20.8
2026

Delårsrapport Q2'26